Gold tier: mechanically validated evidence, with its primary source.
206 evidence items · page 6 / 9
311 genomesA total of 311 SARS-CoV-2 genomes were generated from samples collected in coastal Kenya between 17th March and 31st July 2020.
KenyaCOVID-19observed 17th March and 31st July 2020published 2021Nature communicationseurope_pmcdocument of 2 observations
63 %Lineage B.1 accounted for 723 out of 1139 sequenced SARS-CoV-2 infections in Coastal Kenya, representing 63% of all sequenced cases.
KenyaCOVID-19published 2022eLifeeurope_pmcdocument of 6 observations
1 %Two (1%) patients with malaria co-infection and three (1%) without malaria died.
KenyaCOVID-19 · paludismepublished 2026The Lancet. Global healthPubMeddocument of 8 observations
39.9 %If SARS-CoV-2 self-testing were available, 39.9% of participants would be likely to use it.
KenyaCOVID-19observed August 2021published 2022International journal of public healtheurope_pmcdocument of 6 observations
1.56 aORSRI patients presenting with sore throat were more likely to have SARS-CoV-2 infection compared to those who did not, with an adjusted odds ratio of 1.56.
KenyaCOVID-19observed July 2022 to October 2023published 2026VaccinePubMeddocument of 8 observations
27.9 %SARS-CoV-2 test results were positive in 2,364 (27.9%) of the 8,471 patients that underwent testing.
KenyaCOVID-19observed May 2020 to December 2022published 2024BMC infectious diseasesPubMeddocument of 3 observations
28 daysAntibody-neutralising potencies peaked at day 28 after PCR testing.
KenyaCOVID-19published 2023Wellcome open researcheurope_pmcdocument of 4 observations
50 %Seroreversion occurred in about half of mothers and infants.
KenyaCOVID-19observed between May 1, 2020-February 1, 2022published 2023PloS onePubMeddocument of 8 observations
2.15 aPRAmong participants in Kenya, Uganda, Tanzania, and Nigeria between 19 July 2022 and 1 March 2024, adjusted prevalence ratio for SARS-CoV-2 infection was 2.15 during the omicron wave compared to non-wave periods.
Kenya · Nigeria · Ouganda · TanzanieCOVID-19observed 19 July 2022 to 1 March 2024published 2025BMC infectious diseasesPubMeddocument of 8 observations
108 introductionsOne hundred eight SARS-CoV-2 introductions in Kenya between March 2020 and September 2022 were associated with the Alpha variant.
KenyaCOVID-19observed March 2020 – September 2022published 2022The genomic epidemiology of SARS-CoV-2 variants of concern in Kenyaeurope_pmcdocument of 8 observationsDOI 10.1101/2022.10.26.22281446
2.73 odds_ratioThe odds of developing COVID-19 symptoms were higher among cases with underlying conditions (odds ratio = 2.73, P < 0.001).
KenyaCOVID-19published 2022Journal of global healthPubMeddocument of 24 observations
31.1 %31.1% of pregnant women in Kenya were concerned about COVID-19 vaccine effectiveness.
KenyaCOVID-19observed 2022published 2024International journal of environmental research and public healtheurope_pmcdocument of 5 observationsDOI 10.3390/ijerph21010098
45 %45% of the RT-PCR positive samples were paired with positive serum IgG antibody samples in the Coastal part of Kenya between 17th March 2020 and 30th June 2021.
KenyaCOVID-19observed 17th March 2020 to 30th June 2021published 2022Wellcome open researcheurope_pmcdocument of 10 observations
30 %An estimated 30–50% of residents in the major urban counties of Kenya were infected during the first wave of SARS-CoV-2 transmission.
KenyaCOVID-19observed up to the end of September 2020published 2021Wellcome open researcheurope_pmcdocument of 2 observations
10.5 %A minority of participants (10.5%) had ever tested for SARS-CoV-2.
KenyaCOVID-19observed August 2021published 2022International journal of public healtheurope_pmcdocument of 6 observations
4 %The prevalence of detectable SARS-CoV-2 antibodies was 4% among participants without HIV in Western Kenya.
KenyaCOVID-19 · VIH/sidaobserved January through March 2020published 2021AIDS (London, England)PubMeddocument of 3 observations
28.5 %The most common comorbidities among patients with laboratory-confirmed COVID-19 were hypertension (28.5%), diabetes mellitus (26.1%), and heart disease (4.1%).
KenyaCOVID-19published 2022PloS onePubMeddocument of 7 observations
49.2 yearsIn the sample of 582 patients admitted with laboratory-confirmed COVID-19, the mean age was 49.2 years (SD = 15.2), with 68% being men.
KenyaCOVID-19published 2022PloS onePubMeddocument of 7 observations
52.2 %52.2% of COVID-19 positive DKA patients had moderate DKA.
KenyaCOVID-19 · diabetic ketoacidosis (DKA)observed during COVID-19 pandemicpublished 2024BMC endocrine disordersPubMeddocument of 16 observations
1.37 aORMortality during COVID-19 hospitalization was 37% higher among patients with diabetes (adjusted odds ratio [aOR] 1.37).
KenyaCOVID-19 · diabète (non précisé)published 2025Global health actionPubMeddocument of 11 observations
73 %Lineage B.1 accounted for 73% of sequenced SARS-CoV-2 infections in Coastal Kenya during Wave 1.
KenyaCOVID-19observed Wave 1published 2022eLifeeurope_pmcdocument of 6 observations
1.6 %The case fatality rate of COVID-19 in Kenya was 1.6% as of July 30, 2020.
KenyaCOVID-19observed July 30, 2020published 2022Journal of global healthPubMeddocument of 24 observations
300 transition_eventsASR analysis identified more than 300 virus location transition events during March 2020 to February 2021, comprising 69 viral imports into Coastal Kenya, 93 viral exports from coastal Kenya, and 191 inter-county import/export events.
KenyaCOVID-19observed March 2020 - February 2021published 2021Transmission networks of SARS-CoV-2 in coastal Kenya during the first two waves: a retrospeurope_pmcdocument of 4 observationsDOI 10.1101/2021.07.01.21259583
23 %Of the 2,568 symptomatic individuals tested, 588 (23%) were SARS-CoV-2 positive by RT-PCR in the Coastal part of Kenya between 17th March 2020 and 30th June 2021.
KenyaCOVID-19observed 17th March 2020 to 30th June 2021published 2022Wellcome open researcheurope_pmcdocument of 10 observations
5 %The mortality rate was 5% among patients admitted with laboratory-confirmed COVID-19 infection at Aga Khan University Hospital, Nairobi.
KenyaCOVID-19published 2022PloS onePubMeddocument of 7 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.